These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
233 related articles for article (PubMed ID: 31678159)
61. Novel CLN8 mutations confirm the clinical and ethnic diversity of late infantile neuronal ceroid lipofuscinosis. Reinhardt K; Grapp M; Schlachter K; Brück W; Gärtner J; Steinfeld R Clin Genet; 2010 Jan; 77(1):79-85. PubMed ID: 19807737 [TBL] [Abstract][Full Text] [Related]
62. CLN6 disease caused by the same mutation originating in Pakistan has varying pathology. Guerreiro R; Bras JT; Vieira M; Warrier V; Agrawal S; Stewart H; Anderson G; Mole SE Eur J Paediatr Neurol; 2013 Nov; 17(6):657-60. PubMed ID: 23735787 [TBL] [Abstract][Full Text] [Related]
63. Altered protein secretion in Batten disease. Huber RJ Dis Model Mech; 2021 Dec; 14(12):. PubMed ID: 34870700 [TBL] [Abstract][Full Text] [Related]
64. Progress in gene and cell therapies for the neuronal ceroid lipofuscinoses. Donsante A; Boulis NM Expert Opin Biol Ther; 2018 Jul; 18(7):755-764. PubMed ID: 29936867 [TBL] [Abstract][Full Text] [Related]
65. The neuronal ceroid-lipofuscinoses (Batten disease): a new class of lysosomal storage diseases. Bennett MJ; Hofmann SL J Inherit Metab Dis; 1999 Jun; 22(4):535-44. PubMed ID: 10407785 [TBL] [Abstract][Full Text] [Related]
66. Infantile neuronal ceroid lipofuscinosis: no longer just a 'Finnish' disease. Hofmann SL; Das AK; Lu JY; Wisniewski KE; Gupta P Eur J Paediatr Neurol; 2001; 5 Suppl A():47-51. PubMed ID: 11589007 [TBL] [Abstract][Full Text] [Related]
67. An integrated strategy for the diagnosis of neuronal ceroid lipofuscinosis types 1 (CLN1) and 2 (CLN2) in eleven Latin American patients. Kohan R; Cismondi IA; Kremer RD; Muller VJ; Guelbert N; Anzolini VT; Fietz MJ; Ramírez AM; Halac IN Clin Genet; 2009 Oct; 76(4):372-82. PubMed ID: 19793312 [TBL] [Abstract][Full Text] [Related]
68. Novel missense mutation in CLN8 in late infantile neuronal ceroid lipofuscinosis: The first report of a CLN8 mutation in Japan. Katata Y; Uematsu M; Sato H; Suzuki S; Nakayama T; Kubota Y; Kobayashi T; Hino-Fukuyo N; Saitsu H; Kure S Brain Dev; 2016 Mar; 38(3):341-5. PubMed ID: 26443629 [TBL] [Abstract][Full Text] [Related]
75. CLN5, a novel gene encoding a putative transmembrane protein mutated in Finnish variant late infantile neuronal ceroid lipofuscinosis. Savukoski M; Klockars T; Holmberg V; Santavuori P; Lander ES; Peltonen L Nat Genet; 1998 Jul; 19(3):286-8. PubMed ID: 9662406 [TBL] [Abstract][Full Text] [Related]
76. Lysoplex: An efficient toolkit to detect DNA sequence variations in the autophagy-lysosomal pathway. Di Fruscio G; Schulz A; De Cegli R; Savarese M; Mutarelli M; Parenti G; Banfi S; Braulke T; Nigro V; Ballabio A Autophagy; 2015; 11(6):928-38. PubMed ID: 26075876 [TBL] [Abstract][Full Text] [Related]
77. Neuronal ceroid lipofuscinoses caused by defects in soluble lysosomal enzymes (CLN1 and CLN2). Hofmann SL; Atashband A; Cho SK; Das AK; Gupta P; Lu JY Curr Mol Med; 2002 Aug; 2(5):423-37. PubMed ID: 12125808 [TBL] [Abstract][Full Text] [Related]
78. Batten disease: clinical aspects, molecular mechanisms, translational science, and future directions. Dolisca SB; Mehta M; Pearce DA; Mink JW; Maria BL J Child Neurol; 2013 Sep; 28(9):1074-100. PubMed ID: 23838031 [TBL] [Abstract][Full Text] [Related]
79. A lysosomal enigma CLN5 and its significance in understanding neuronal ceroid lipofuscinosis. Basak I; Wicky HE; McDonald KO; Xu JB; Palmer JE; Best HL; Lefrancois S; Lee SY; Schoderboeck L; Hughes SM Cell Mol Life Sci; 2021 May; 78(10):4735-4763. PubMed ID: 33792748 [TBL] [Abstract][Full Text] [Related]
80. Intrathecal enzyme replacement therapy improves motor function and survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis. Lu JY; Nelvagal HR; Wang L; Birnbaum SG; Cooper JD; Hofmann SL Mol Genet Metab; 2015; 116(1-2):98-105. PubMed ID: 25982063 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]